{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:20:56Z","timestamp":1762521656314,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.cgh.2014.02.040","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T01:22:46Z","timestamp":1395883366000},"page":"1856-1861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Risk of Clostridium difficile Infection in Hospitalized Patients Receiving Metronidazole for a Non\u2013C difficile Infection"],"prefix":"10.1016","volume":"12","author":[{"given":"Sandra","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlow B.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Tarchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Zaleski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjon","family":"Vatanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyssette","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Castro\u2013Pavia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2014.02.040_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/QCO.0b013e32834748e5","article-title":"Epidemiology and control of Clostridium difficile infections in healthcare settings: an update","volume":"24","author":"Barbut","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cgh.2014.02.040_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/clinids\/23.Supplement_1.S102","article-title":"Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use","volume":"23","author":"Ho","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2014.02.040_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/AAC.35.1.208","article-title":"Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery","volume":"35","author":"Privitera","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cgh.2014.02.040_bib4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-145-10-200611210-00008","article-title":"Narrative review: the new epidemic of Clostridium difficile-associated enteric disease","volume":"145","author":"Bartlett","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2014.02.040_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1086\/596703","article-title":"Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study","volume":"48","author":"Gravel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2014.02.040_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1086\/649213","article-title":"Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality","volume":"50","author":"Miller","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2014.02.040_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3201\/eid1203.051064","article-title":"Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003","volume":"12","author":"McDonald","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cgh.2014.02.040_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jhin.2009.10.016","article-title":"Economic healthcare costs of Clostridium difficile infection: a systematic review","volume":"74","author":"Ghantoji","year":"2010","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cgh.2014.02.040_bib9","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","article-title":"Host and pathogen factors for Clostridium difficile infection and colonization","volume":"18","author":"Loo","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2014.02.040_bib10","first-page":"545","article-title":"Clinical inquiry: what risk factors contribute to C difficile diarrhea?","volume":"60","author":"Fashner","year":"2011","journal-title":"J\u00a0Fam Pract"},{"key":"10.1016\/j.cgh.2014.02.040_bib11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"P\u00e9pin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2014.02.040_bib12","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1086\/588291","article-title":"Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain","volume":"46","author":"Carignan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2014.02.040_bib13","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2014.02.040_bib14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archinternmed.2010.89","article-title":"Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection","volume":"170","author":"Howell","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2014.02.040_bib15","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1111\/j.1572-0241.2008.01975.x","article-title":"Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients","volume":"9","author":"Aseeri","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2014.02.040_bib16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2014.02.040_bib17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2014.02.040_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0195-6701(02)00400-0","article-title":"Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection","volume":"54","author":"Wilcox","year":"2003","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cgh.2014.02.040_bib19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jac\/dkq038","article-title":"Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic","volume":"65","author":"Chalmers","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cgh.2014.02.040_bib20","first-page":"1201","article-title":"Severe Clostridium difficile\u2013associated disease in populations previously at low risk\u2013four states, 2005","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cgh.2014.02.040_bib21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1572-0241.2007.01780.x","article-title":"A\u00a0national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2014.02.040_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2007.128231","article-title":"Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease","volume":"57","author":"Ananthakrishnan","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2014.02.040_bib23","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1469-0691.2009.03077.x","article-title":"Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis","volume":"16","author":"Price","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cgh.2014.02.040_bib24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/644757","article-title":"Proposed checklist of hospital interventions to decrease the incidence of healthcare associated Clostridium difficile infection","volume":"30","author":"Abbett","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cgh.2014.02.040_bib25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","article-title":"Meta-analysis of probiotics for the prevention of antibiotic-associated diarrhea and the treatment of Clostridium difficile disease","volume":"101","author":"McFarland","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2014.02.040_bib26","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7326\/0003-4819-157-12-201212180-00563","article-title":"Probiotics for the\u00a0prevention of Clostridium difficile\u2013associated diarrhea. A systematic review and meta-analysis","volume":"12","author":"Johnston","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2014.02.040_bib27","first-page":"CD004827","article-title":"Probiotics for the prevention of pediatric antibiotic-associated diarrhea","volume":"11","author":"Johnston","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2014.02.040_bib28","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(13)61218-0","article-title":"Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"382","author":"Allen","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2014.02.040_bib29","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/MPG.0b013e3181660694","article-title":"Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis","volume":"46","author":"Marcobal","year":"2008","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2014.02.040_bib30","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/429916","article-title":"Saccharomyces cerevisiae fungemia: an emerging infectious disease","volume":"40","author":"Munoz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2014.02.040_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1086\/380455","article-title":"Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG","volume":"38","author":"Salminen","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2014.02.040_bib32","first-page":"371","article-title":"Ten years of prospective Clostridium difficile\u2013associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982\u20131991","volume":"15","author":"Olson","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cgh.2014.02.040_bib33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/cis457","article-title":"Does doxycycline protect against development of Clostridium difficile infection?","volume":"55","author":"Doernberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2014.02.040_bib34","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/AAC.00090-08","article-title":"Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease","volume":"52","author":"Al-Nassir","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356514004455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356514004455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:15:14Z","timestamp":1761542114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356514004455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1542356514004455"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2014.02.040","relation":{},"ISSN":["1542-3565"],"issn-type":[{"type":"print","value":"1542-3565"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Clostridium difficile Infection in Hospitalized Patients Receiving Metronidazole for a Non\u2013C difficile Infection","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2014.02.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}